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Actors as patients 
enhance education
S P E E D I N G  S T R O K E  C A R E     A D V A N C I N G  P S Y C H I A T R Y     M A T C H  D A Y
Second-year MD/PhD student Kelly Hill captured this poetic winter scene along her running path in Forest Park.  
Washington University Medical Center is just visible above the trees  in this photo titled “Our Backyard.”
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Rolling, crawling, and some already walking, 20 infants  
put “Baby Day” in full motion. Accurately guessing the 
babies’ ages was the goal of first-year physical therapy 
students, using motor development assessments 
they’ve learned in Kinesiology (motion science) class. 
Clockwise from left, the babies and their proud moms: 
Isa with physical therapy instructor Patty McGee, DPT; 
Emma with Carolyn Holman, DPT ’06; and Sophie with 
physical therapy instructor Stacy Tylka, DPT.
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 24  Match Day dance
COVER  Second-year students Jenny 
Yu and Lawrence Benjamin interact with 
standardized patient Theresa George, a 
local actress simulating real symptoms.  
Dehra A. Glueck, MD (second from right), 
medical director of the Standardized 
Patient Program, offers some helpful 
guidance. To learn more, turn to page 10.   
P H O T O  B Y  R O B E R T  B O S T O N
The patient will see you now
10 Committed to helping medical students become better doctors, nearly 70 local 
professional actors portray real patients and 
give critical feedback.  
Psychiatry’s therapeutic frontier
 15 As part of the Taylor Family Institute for Innovative Psychiatric Research, basic and 
clinical investigators are teaming up to 
develop novel drugs for mental illness. 
Expediting stroke treatment                
18 A multidisciplinary team provides some of the fastest stroke critical care in the 
U.S., redening time-critical protocols and 
pioneering evaluation methods.
Meeting their match  
 24 is year’s graduating medical students learn where they will do their residency training.
 2 Pulse
 26 Alumni & Development
  26 Classnotes
  28 Midpoint update —  
 Leading Together:  
 The Campaign for    
 Washington University
  
34  Fellowships help promising students  
      achieve their goals. 
18   
Stroke: When  
seconds count
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riendly microbes in the intestinal 
tracts of healthy American children 
have numerous antibiotic-resistance 
genes, according to a pilot study by School 
of Medicine scientists. The genes are cause 
for concern because they can be shared with 
harmful microbes, interfering with antibiotic 
effectiveness in ways that can contribute to 
serious illness or death.
“From birth to age 5, children receive 
more antibiotics than during any other 
five-year time span in their lives,” said senior 
author Gautam Dantas, PhD, assistant profes-
sor of pathology and immunology. “Frequent 
exposure to antibiotics accelerates the spread 
of antibiotic resistance. Our research high-
lights how important it is to only use these 
drugs when they are truly needed.”
With funding from the Children’s 
Discovery Institute, the International Center 
for Advanced Renewable Energy and 
Sustainability, the National Academies Keck 
Futures Initiative and the National Institutes 
of Health (NIH), the researchers analyzed fecal 
samples from 22 infants and children ages 
6 months to 19 years. Phillip I. Tarr, MD, the 
Melvin E. Carnahan Professor of Pediatrics at 
the medical school, provided the samples.
Despite the small sample size, the analysis 
identified 2,500 new antibiotic-resistance 
genes, expanding the list of known antibiotic-
resistance genes by more than 30 percent.
“Microbes have been battling each other 
for millennia, regularly inventing new antibi-
otic-synthesis genes to kill off rivals and new 
antibiotic-resistance genes to defend them-
selves,” Dantas said. 
The scientists identified the new resistance 
genes by testing intestinal microbial DNA from 
the children against 18 antibiotics. The identi-
fied genes impaired the effectiveness of all  
but four of the drugs. 
Babies lack microbes in their intestinal 
tracts at birth. They establish their communi-
ties of gut microbes through ingestion of 
microorganisms in their environment — from 
crawling on the floor, for example, to putting 
toys and other objects into their mouths, to 
contact with their primary caregivers. 
According to the Centers for Disease 
Control and Prevention, antibiotic-resistant 
infections cause at least 2 million illnesses  
and 23,000 deaths annually, adding $20 billion 
in health-care costs. Methicillin-resistant 
Staphylococcus aureus now causes more  
U.S. deaths than HIV. Scientists use the term 
“resistome“ to refer to the collective antibiotic-
resistance genes of a microbial community.
“There were quite a few resistance genes  
in microbes from every child we looked at,” 
Dantas said. “This was true even in children 
who were only 6 months old. When we com-
pared their resistomes to those of older children, 
there didn’t seem to be much difference.”
Gut microbes in healthy kids carry antibiotic-resistance genes
Early exposure
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“There were quite a 
few resistance genes 
in microbes from every 
child we looked at.” 
—  G AU TA M  DA N TA S ,  P h D
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Babies who develop leukemia during the rst year of life 
appear to inherit an unfortunate combination of genetic vari-
ations that can make the infants highly susceptible to the dis-
ease, according to a new study at the School of Medicine and 
the University of Minnesota. e research is available online 
in the journal Leukemia.
Doctors have long puzzled over why it is that babies just a 
few months old sometimes develop cancer. As infants, they 
have not lived long enough to accumulate a critical number  
of cancer-causing mutations.
e babies appear to have inherited rare genetic variants from 
both parents that by themselves would not cause problems,  
but in combination put the infants at high risk of leukemia. 
ese variants most oen occurred in genes known to be 
linked to leukemia in children, said Todd E. Druley, MD, 
PhD, a Washington University pediatric oncologist who  
treats patients at St. Louis Children’s Hospital. 
Only about 160 infant leukemia cases are diagnosed annu-
ally in the U.S. But unlike leukemia in older children, which 
oen can be cured, about half of infants who develop leuke-
mia die of the disease. 
e researchers sequenced all the genes in the DNA of 
healthy cells from 23 infants with leukemia and their mothers. 
Looking at genes in the healthy cells helped the researchers 
understand which genetic variations were passed from a 
mother to her child, and by process of elimination, the scien-
tists could determine the father’s contribution to a baby’s DNA.
Among the families studied, there was no history of pedi-
atric cancers. Other children in the families typically don’t 
develop leukemia because a roll of the genetic dice likely 
means they did not inherit the same combination of harmful 
genetic changes, he added.
Blue behemoth  Workers lower a cyclotron into its East 
Building vault on the Medical Campus. The unit, in the works for 
more than a decade, is a particle accelerator that will produce radio-
active compounds, many of which are used with positron emission 
tomography (PET) scanners to detect types of cancers. Eventually, the 
new cyclotron will replace two others on campus that make these 
compounds. The new cyclotron will have higher energy and increased 
capacity to produce needed PET drugs.The Cyclotron Facility is part of 
Washington University’s Mallinckrodt Institute of Radiology.
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Holtzman named AAAS fellow
Michael J. Holtzman, MD, has been named a fellow of the 
American Association for the Advancement of Science 
(AAAS). e rank of fellow is the highest honor awarded  
by AAAS in recognition of distinguished eorts to advance 
science or its applications.
Holtzman, the Selma and Herman Seldin 
Professor of Medicine, is being honored for 
his contributions to understanding and treat-
ing chronic lung diseases such as asthma 
and chronic obstructive pulmonary disease 
and the role of respiratory viruses in these 
disorders.
Holtzman has performed pioneering 
research on the unsuspected link between 
acute viral infection and chronic inamma-
tory disease. His recent insight uncovered 
the possibility that viral infections may reprogram lung  
stem cells as a renewable trigger for chronic inammation. 
In addition to dening the cause of lung disease, 
Holtzman has led the development of a drug discovery  
program that includes new facilities for high-throughput 
screening, medicinal chemistry and structural biology. As 
part of the program, scientists are identifying new thera-
peutics and translating them into practice to reduce excess 
mucus production, combat viral infection and inhibit 
inammation in the airway. 
A key characteristic of Holtzman’s approach has been the 
multidisciplinary nature of his group’s research activities. 
Babies with leukemia inherit 
strong genetic predisposition
Both parents carry DNA variations
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Michael J. Holtzman, MD
Todd E. Druley, MD, PhD, 
studies the genetics  
of leukemia.
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Todd P. Margolis, MD, PhD, has been named head of the 
Department of Ophthalmology and Visual Sciences. With  
the appointment, Margolis also becomes ophthalmologist- 
in-chief at Barnes-Jewish Hospital. 
Margolis comes from the University  
of California, San Francisco (UCSF), 
where he was professor of ophthalmol-
ogy and the Rose B. Williams Chair for 
Research in Corneal Diseases. 
His clinical expertise is in the  
diagnosis and management of infectious  
and inammatory eye disease, with a 
particular interest in eye disease due to 
herpes viruses and ocular infections in 
immune-compromised patients.
A 1977 graduate of Stanford 
University, Margolis subsequently received a doctorate in 
neuroscience and a medical degree from UCSF in 1984. 
Aer an internship in San Francisco, he trained as a resi-
dent in ophthalmology at UCSF and later did subspecialty 
training in corneal and external diseases at the F.I. Proctor 
Foundation. He completed postdoctoral research training 
in the Department of Microbiology and Immunology at the 
University of California, Los Angeles, where he served as a 
visiting assistant professor at the Jules Stein Eye Institute.
Margolis replaces Michael A. Kass, MD, who led the 
department since 1999, building it into one of the largest eye 
and vision research centers in the U.S. Kass will maintain a 
clinical practice and continue serving as senior associate  
dean for human research protection.
Head of ophthalmology named
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Good medicine Rowan Karvas, a research technician in 
radiation oncology, and Daniel Kober, a PhD student in microbiology, 
play “Sonata for Two Clarinets ” at the third annual winter concert. 
Held in the Center for Advanced Medicine lobby, the free concert 
showcases Medical Center musicians in a range of genres. The pro-
gram is designed to connect current and future health-care providers 
through music and bring comfort to patients and guests. 
Widely used treatments for type 2 diabetes have dierent 
eects on the hearts of men and women, even as the drugs 
control blood sugar equally well in both sexes, according  
to School of Medicine researchers.
In particular, the commonly prescribed diabetes drug 
metformin had positive eects on heart function in women 
but not in men, who experienced a shi in metabolism 
thought to increase the risk of heart failure.
“We saw dramatic sex dierences in how the heart 
responds to the dierent therapies,” said senior author 
Robert J. Gropler, MD, professor of radiology. e study 
appeared in the American Journal of Physiology — Heart 
and Circulatory Physiology.
To the researchers’ knowledge, this is the rst study to 
investigate sex dierences in the heart’s response to diabetes 
treatments. In type 2 diabetes, the pancreas continues to 
make insulin, but the body can’t use it eectively to move 
glucose out of the blood and into the tissues. And for reasons 
that are not entirely clear, patients with diabetes are at higher 
risk for heart failure.
“It is imperative that we gain understanding of diabetes 
medications and their impact on the heart to design optimal 
treatment regimens for patients,” said Janet B. McGill, MD, 
professor of medicine and a study co-author. 
e investigators evaluated commonly prescribed diabe-
tes drugs in 78 patients. e research suggests that divergent 
responses in men and women may provide at least a partial 
explanation for the conicting data surrounding some dia-
betes drugs. Specically, the proportion of men and women 
participating in a clinical trial may play an unappreciated 
role in whether drugs are deemed safe and eective.
Diabetes drugs affect the hearts 
of men and women differently
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Janet B. McGill, MD, 
and Robert J. Gropler, 
MD, look through the 
PET scanner they and 
their colleagues used 
to study the heart’s 
response to common 
diabetes therapies. 
They found large 
differences in heart 
metabolism between 
men and women 
taking widely used 
diabetes drugs.
Todd P. Margolis, MD, PhD
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he School of Medicine now offers 
genetic testing to help diagnose and 
treat patients with heart disorders 
that can lead to sudden death. 
The new test, offered though the school’s 
Genomics and Pathology Services (GPS) and 
developed in collaboration with Washington 
University cardiologists, analyzes genes linked 
to arrhythmias and cardiomyopathies. 
Physicians who treat patients with indica-
tions of these heart conditions can submit a 
blood sample for gene sequencing. In two to 
three weeks, they receive a report from GPS 
describing any mutations identified in the 
patient’s DNA that may contribute to disease 
and affect response to treatment. 
“Results from this test can help us refine 
diagnoses and allow us to personalize man-
agement and treatment of our patients,” said 
Phillip S. Cuculich, MD, assistant professor of 
medicine and one of the cardiologists involved 
in test development. “The results also may 
help family members of affected patients 
decide if they want to be tested to see if they 
are at risk for developing the disease.”
Alerting to the risk for sudden death
T
G E N E T I C  T E S T I N G
Called the Washington University 
CardioGene Set, the test builds on another 
first-of-its-kind test offered by GPS that 
analyzes multiple genes in tumors. Seeking 
genomic clues to personalize cancer diagnosis 
and treatment, oncologists nationwide have 
been sending tissue samples to GPS for this 
test for two years. 
“The CardioGene Set is the next major  
step in our effort to bring the promise of 
human genomics to the clinic,” said Karen 
Seibert, PhD, director of GPS. “With rapid and 
sensitive gene-sequencing technology, we 
check dozens of heart disease genes simulta-
neously to cost-effectively identify the likely 
genetic cause.”
The cardiac testing panel includes genes 
linked to eight cardiac disorders that are char-
acterized by irregular heartbeats (arrhythmias) 
or heart muscle problems (cardiomyopathies). 
For example, the test analyzes the 
sequences of genes linked to long-QT syn-
drome, a rare inherited arrhythmia that length-
ens the time between heartbeats, potentially 
causing heart palpitations or cardiac arrest. 
These genes can help doctors identify particu-
lar subtypes of long QT. Different forms of  
long QT respond to different therapies, so this 
information helps guide treatment decisions.
Patients with hypertrophic cardiomyopa-
thy (HCM), a thickening of the heart muscle 
that can lead to sudden cardiac arrest and 
other problems, also can benefit from the 
CardioGene Set. 
HCM is infamous for causing sudden fatal 
cardiac arrests in young athletes who never 
showed any symptoms of heart problems. 
Genetic diagnosis of this condition may lead 
physicians to advise a patient against physical 
overexertion.
Residents honored 
with high-flying 
breakfast
The Division of Medical Education treated residents 
to games, prizes and lots of good food in “Funuary” 
to keep them energized and ready to face the final 
weeks of winter. Above: Victoria J. Fraser, MD, the 
Adolphus Busch Professor of Medicine and chair of the 
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Department of Medicine, and Melvin S. Blanchard, 
MD,  division chief and associate professor of med-
icine, showed off their culinary — and pancake-
flipping — skills as they served breakfast to the 
hardworking house staff.
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In the largest assessment of substance use among people 
with severe psychiatric illness, researchers at the School of 
Medicine and the University of Southern California have 
found that rates of smoking, drinking and drug use are sig-
nicantly higher among those who have psychotic disorders 
than among those in the general population. e study is 
published online in the journal JAMA Psychiatry.
e nding is of particular concern because people with 
severe mental illness are more likely to die at a younger age.
“ese patients tend to pass away much younger, with 
estimates ranging from 12 to 25 years earlier than indi-
viduals in the general population,” said rst author Sarah 
M. Hartz, MD, PhD, assistant 
professor of psychiatry at 
Washington University. 
“ey don’t die from 
drug overdoses or com-
mit suicide — the kinds 
of things you might 
suspect in severe psy-
chiatric illness. ey 
die from heart disease 
and cancer, problems 
caused by chronic alcohol 
and tobacco use.”
e study analyzed smok-
ing, drinking and drug use in 
nearly 20,000 people, includ-
ing 9,142 psychiatric patients 
diagnosed with schizo-
phrenia, bipolar disorder or 
schizoaective disorder. 
e investigators also assessed nicotine use, heavy drink-
ing, heavy marijuana use and recreational drug use in more 
than 10,000 healthy people without mental illness. 
e researchers found that 30 percent of those with 
severe psychiatric illness engaged in binge drinking, dened 
as drinking four servings of alcohol at one time. e rate of 
binge drinking in the general population is 8 percent.
Among those with mental illness, more than 75 percent 
were regular smokers, compared with 33 percent of those in 
the control group. ere were similar ndings with heavy 
marijuana use: 50 percent of people with psychotic disorders 
used marijuana regularly, versus 18 percent in the general 
population. Half of those with mental illness also used other 
illicit drugs, while the rate of recreational drug use in the 
general population is 12 percent. 
Alcohol, tobacco, drug use far 
higher in severely mentally ill
Links with shorter life expectancy
Going barefoot in parts of Africa, Asia and South America 
contributes to hookworm infections, which aict an esti-
mated 700 million of the world’s poor. e parasitic worm 
lives in the soil and enters the body through the feet. By feed-
ing on victims’ blood, the worms cause anemia and, in chil-
dren, stunted growth and learning problems. 
Now, School of Medicine researchers 
have decoded the genome of the 
hookworm, Necator americanus, 
nding clues to how it infects 
and survives in humans and 
aiding in the development 
of new therapies to combat 
hookworm disease. 
“is information will 
accelerate development of 
new diagnostic tools and vac-
cines against the infection,” said 
Makedonka Mitreva, PhD, assistant pro-
fessor of medicine and of genetics and a member of e 
Genome Institute at Washington University.  
 In the U.S. and other industrial countries, hookworms are 
gaining attention for their therapeutic potential in the treat-
ment of autoimmune conditions, such as inammatory bowel 
disease, multiple sclerosis, asthma and even allergies. 
e scientists discovered that hookworms, to evade detec-
tion by the host immune system, appear to suppress mol-
ecules that promote inammation. is same approach may 
prove valuable in the treatment of autoimmune conditions. 
Researchers decode hookworm DNA
 
A higher incidence of 
chronic alcohol and  
tobacco use causes more 
deaths than suicide.
Scholars in pediatrics  The School of Medicine and its 
Department of Pediatrics have established funding for three pediatric 
scholars named in honor of a trio of highly regarded former pediatri-
cians at the university. The medical school is funding these awards 
with $3 million to be divided among the three faculty members, in 
support of their time and efforts devoted to scholarship and teaching. 
The funding recipients, each of whom practices at St. Louis Children’s 
Hospital, are: Paul W. Hruz, MD, PhD, as the Julio V. Santiago, MD, 
Scholar in Pediatrics; Shalini Shenoy, MD, as the Teresa J. Vietti, MD, 
Scholar in Pediatrics; and Andrew J. White, MD, as the Philip R. Dodge, 
MD, Scholar in Pediatrics. The scholars are appointed for three years.
Hruz Shenoy White
6  Washington University School of Medicine
An estimated 700 million 
people worldwide are infected 
with hookworms, which feed 
on blood, causing anemia and, 
in children, stunted growth 
and learning problems.
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lder adults who have 20/20 vision 
in their eye doctors’ offices may 
not see as well at home. School 
of Medicine researchers suggests dim lighting 
may be the culprit.
Their study is published online in the  
journal JAMA Ophthalmology.
“It’s very common for older patients to 
have concerns about their vision but then 
test well on the eye charts when we examine 
them,” said first author Anjali M. Bhorade, 
MD, a Washington University ophthalmolo-
gist at Barnes-Jewish Hospital. “In this study, 
we found that vision in patients’ homes was 
significantly worse than in the clinic. The major 
factor contributing to this difference was poor 
lighting in the home.” 
The researchers studied 175 patients ages 
55-90. These included 126 with glaucoma.  
All patients had their vision measured at home 
and at the Glaucoma and Comprehensive  
Eye Clinics at the School of Medicine. 
The average scores on vision tests were 
better in the clinic than at home, Bhorade said. 
Nearly 30 percent of the patients with glau-
Shining a light on older adults’ vision
O
O P H T H A L M O L O G Y  R E S E A R C H
tl  
coma were able to read at least two or more 
extra lines on an eye chart in the clinic than on 
the same chart at their homes, and 39 percent 
of those with advanced glaucoma read three 
or more additional lines in the clinic. 
“Older adults with and without glaucoma 
had similar differences in vision between the 
clinic and home,” said Bhorade, an associate 
professor of ophthalmology and visual sci-
ences. “These differences occurred not only 
with distance and near vision, but with con-
trast sensitivity and glare testing, too. The  
biggest difference we observed was for dis-
tance vision in patients with advanced glau-
coma. They had even bigger declines in  
vision at home.”
Lighting levels were below the recom-
mended range in more than 85 percent of  
the homes visited.
 “Since most older adults spend the major-
ity of time at home, our study suggests that 
better lighting may increase vision and pos-
sibly improve the quality of life for a large 
number of people,” Bhorade said. 
Although the study didn’t look specifically 
at potential dangers associated with low light, 
such as falls, other research has determined 
that a difference of two or more lines on an  
eye chart is associated with a significant differ-
ence in how a person functions in daily life. 
The findings suggest that a simple solution 
may help older adults function at their maxi-
mum potential. 
“Clinicians should refer their patients for a 
customized in-home evaluation by an occupa-
tional therapist or low-vision rehabilitation spe-
cialist who can make suggestions to optimize 
the lighting in people’s homes,” Bhorade said.
Tread the Med     
Tread the Med, the School of Medicine’s pop-
ular program that encourages employees to 
walk 10,000 steps daily, began Feb. 27 with 
an Olympics-themed kickoff on the Medical 
Campus. Kerri Morgan, an instructor in occu-
pational therapy and neurology, spoke to 
participants about her journey to becoming 
a bronze-medal winner in the 2012 London 
Paralympic games. The event included a 
recap of the most recent Tread the Med and 
recognized top achievers. Participants are 
given pedometers and challenged to record 
progress online — with the ultimate goal 
of  500 miles, or 1 million steps, in 100 days. 
Tread the Med is sponsored by the School of 
Medicine’s Wellness Committee. 
Back row, from left: Susan George, Sarah Fowler-Dixon, Linda Van Zandt, Jamie Rose, Rick Chandel, Debbie Aumer 
and Carla Pinkston. Front row, from left: Nikki Koehnemann, Kerri Morgan and Jacki Epps-Wilbanks. 
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Powerful innovation; precision therapy
Cancer destroyer
adiation oncologists at Washington University 
School of Medicine have a new option for 
treating cancer patients — proton therapy.
The S. Lee Kling Proton Therapy Center, which 
opened in January, provides proton therapy to adult 
patients of the Alvin J. Siteman Cancer Center at Barnes-
Jewish Hospital and Washington University School of 
Medicine and pediatric patients of St. Louis Children’s 
Hospital. Patients eligible for the therapy have cancer 
near vital structures such as the 
spine, brain, heart and eyes.
“Proton therapy is unique 
because it allows for very precise 
adjustments to the radiation beam, 
so we can target tumors,” said 
Jeffrey D. Bradley, MD, director of 
the proton therapy center. “It helps 
to minimize damage to surround-
ing tissue and is especially useful 
when treating growing children.”
For example, treatment of a 
brain tumor with proton therapy 
may be less likely to result in 
blindness or other complications, 
said Bradley, who also is the S. Lee Kling Professor of 
Radiation Oncology at Washington University.
The S. Lee Kling Proton Therapy Center plans to treat 
20 to 25 patients a day. Treatment typically requires daily 
30-minute sessions for two months. The center will serve 
the Midwest; the next closest location offering proton 
therapy is 225 miles away.
The MEVION S250 Proton Therapy System was 
developed and manufactured by Littleton, Mass.-based 
Mevion Medical Systems with the assistance of radiation 
oncologists and physicists at Washington University.
R
Jeffrey D. Bradley, MD, shows 
one of the custom-made  
apertures that precisely  
targets a tumor. 
The proton beam delivers a dose directly to the site of the tumor 
and to the correct depth, leaving critical organs untouched. 
Shown during installation: A superconducting synchrocyclotron proton 
accelerator is a key component of the new proton therapy system.  
This is the first single-room proton therapy unit in the world. The  
$20-million device improves upon traditional systems, which typically are 
housed in football field-sized buildings and cost more than $150 million. ROB
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since 2009, he has suffered from tuberculosis, bouts 
of depression, stomach ulcers, acid reflux, diabetes, 
sleep apnea, migraines, night sweats, chest pains and 
high blood pressure. He looks forward to developing 
many more ailments in the coming years.
Committed to helping medical students 
become better doctors, he is one of nearly 70 local 
professional actors working as standardized patients 
(SPs) at Washington University School of Medicine. 
They portray real patients, and repeatedly subject 
themselves to physical exam by inexperienced hands.  
In this safe practice environment, medical students  
hone their clinical skills.
Through this immersive program that builds in 
complexity over four years, students undergo a  
stunning transformation. Here, they learn to get 
comfortable touching and examining patients, taking 
histories, asking personal questions and writing 
notes. By the program’s conclusion, the students  
will have practiced delivering a terminal diagnosis. 
THE  
PATIENT 
will see you now
Scripted scenarios, intelligent improv  
and informed feedback hone the  
clinical skills of tomorrow’s physicians
B Y  D E B  P A R K E R
10  Washington University School of Medicine
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A high-tech space in the Farrell Learning 
and Teaching Center is dedicated solely to 
SP instruction. Thirteen simulated clinical 
exam rooms and two hospital rooms 
surround a central instruction area. The 
rooms, in effect, are stages equipped with 
recording devices. Instructors follow the 
action on a control panel. Right: Dehra 
A. Glueck, MD, medical director of the 
Standardized Patient Program, with Alan I. 
Glass, MD, clinical skills section leader.
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As the process unfolds, students learn more about 
who they are as individuals and how they can bet-
ter connect with their future patients. In a benet 
not aorded in the real world, SPs are trained to 
critique the students’ techniques — breaking char-
acter aer a simulation and telling them exactly 
what it felt like to be their patient.
Program organizers say, in the real world, most 
people “vote with their feet”: If displeased with 
a doctor’s lack of attentiveness or communica-
tion, they simply won’t come back or won’t follow 
health recommendations.
dent must suspend disbelief, read the door note, 
knock and enter. A standardized patient, already 
in character, awaits.
e challenge: ask the right questions, keep the 
patient on topic, gather information, respond to 
concerns and be empathic.  
“is is about being fully present in the 
moment,” said Jamie Pitt, Standardized Patient 
Program coordinator. As with real practitioners, 
these doctors-to-be must put personal diculties 
aside. Regardless of whether students are having a 
bad day, or if someone cut them o in the parking 
lot, it all becomes secondary to patients’ needs. 
“This changed my idea of what it means to learn 
to be a doctor,” said rst-year student Giuseppe 
D’Amelio. “When we practice on each other, we’re 
just going through the motions. It’s very dierent 
when you don’t know what they (the patients) are 
going to say.”
Lack of condence is a common problem, as 
is talking about highly personal subjects. As rst-
year student Jared Goodman explains: “Unlike 
any other conversation you’ve had in your life,  
you realize that every sensitive detail comes out  
in the rst ve minutes.” 
From bowel movements to sexual behavior, all 
topics are open for discussion. “Up until now, social 
conditioning taught students not to talk about these 
things,” Glueck said. “ey’re not always sure what 
words to use. at’s where we come in.”
rough video playback, students critically 
assess themselves, quickly realizing how oen  
they say “um,” dget, click their pens or look 
down at the oor. With input from faculty men-
tors, students go right back in, adjust the approach 
T H E ST U DE N T M UST 
suspend disbelief, read the 
door note, knock and enter. 
A standardized patient, 
already in character, awaits.
Furniture, equipment, lighting 
— each “classroom” simulates 
a real-world clinical setting. 
Students gain experience and 
confidence through feedback from 
faculty instructors as well as the 
standardized patients. A camera, 
left, records the interactions for 
in-depth evaluation.
 “Patients today tell us, ‘I want you to be a good 
diagnostician and practice evidence-based medi-
cine, but that’s not sucient. I also want you to 
be able to talk to me,’” said Dehra A. Glueck, MD, 
assistant professor of psychiatry and medical direc-
tor of the Standardized Patient Program. Glueck 
also served on a communications skills task force 
for the National Board of Medical Examiners. 
e initial, one-on-one standardized patient 
encounter happens early in the rst year. e stu-
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and try it again. Individualized attention is the 
program’s hallmark. 
In a word, most students describe those early 
experiences as “terrifying”; many walk into the 
simulated exam room, nervous and trembling, not 
exactly sure what to do. Clipboards are dropped. 
Hand sanitizer squirts across the room. Just a 
month before, these students were college kids. 
Now, they must face a patient — albeit, pretend — 
and appear “doctorly.”
e SPs are ready: ey’ve memorized symp-
toms, medication dosages, family medical history 
and work-life balance. 
Together, Glueck, who enjoys screenwriting, 
and Pitt, who acts with local and national theater 
companies, have found their calling. e pair 
researches and develops a wide range of realistic 
scripts, complete with backstories, costume and 
props. Actors are carefully coached and scripts  
are rehearsed extensively. 
Despite thoughtful scriptwriting, the actors  
never know exactly what a student will ask. e 
job requires intense concentration. At times, SPs 
are interviewed by up to 10 students in succession. 
 “It’s not about an Oscar-award-winning  
performance,” Pitt said. “It’s about a consistent, 
reliable portrayal of symptoms. In our auditions,  
we look for people who have experience providing 
honest, constructive feedback without any  
medical biases.”
“You had a good demeanor,” ve-year SP vet-
eran Aarya Locker told one student. “I think our 
rapport derailed a bit when I asked you a question 
and you didn’t know the answer. It’s always fair 
to say, ‘I don’t know. Let me research that and get 
back to you.’ I would have been oundering a bit, 
had I le the oce without a solid understanding 
of the next steps I should take with my child.”  
In one small-group session, a student decided 
his peers were “dancing around the subject too 
much.” He went into the exam room and atly told 
the SP, “You’ve got cancer.” e SP burst into tears.
“e actors respond exactly to what’s in front 
of them,” Glueck said. “And this dramatically 
changes what a student can learn. In the student’s 
second attempt, he gave the diagnosis and met  
the patient where she was, rather than thinking  
he knew how it should be done.”
St. Louis’ large professional acting community 
oers expertise and versatility. “It’s an absolute 
dream to play someone else and see if it’s believable,” 
LIGHTS, CAMERA, 
ACTION !
Sampling the SP repertoire
Bill Worthington, a 56-year-old male, 
unemployed, complains of discomfort 
in the chest, problems at home.
orn
Jennifer Walsh, a 23-year-old female,  
in for a routine checkup, exhibits  
signs of abusive physical injuries.
orn
Anna Smith, a 30-year-old female 
smoker, presents for shortness  
of breath and is discouraged after  
a recent failed attempt to quit.
orn
Travis Jones, a 16-year-old male,  
in for evaluation after his mother  
found text messages about suicide; 
reports issues at school after  
coming out as gay.
orn
Fred Johnson, a 70-year-old male,  
in because his wife says he has 
trouble remembering things. 
orn
Alice McCoy, a 46-year-old female, 
nervously awaits biopsy results.
Standing before the wall of local acting talent that fuels the Standardized Patient 
Program, coordinator Jamie Pitt (left) reviews a script with Aarya Locker.
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For many medical school alumni,  fellow classmates were the  first “standardized patients.”   
“We learned physical exam skills on each 
other,” said Alison J. Whelan, MD, senior 
associate dean for education at the medi-
cal school. “There was no instruction on 
communication. Over time, the medical 
community has realized that body lan-
guage does matter — how you sit, how 
you look at a patient, how you acknowl-
edge what they are saying.”
 Nationally, medical schools are  
paying more attention to so-called  
“soft” skills and adding standardized 
patient programs into their curriculums.
In 2004, the National Board of 
Medical Examiners added the Step 2 
Clinical Skills component, a pass/fail test 
that is one of three steps students  
must complete before applying for a 
medical license. 
In Step 2, fourth-year medical  
students travel to a testing center and 
assess 12 standardized patients over 
eight hours, with 15 minutes for each 
encounter and 10 minutes to record  
each patient note. 
Prior to taking Step 2, Washington 
University requires students to com-
plete an in-house Clinical Competency 
Exam — in which they must evaluate six 
standardized patients in a day. Not all 
medical schools offer this preparatory 
advantage for Step 2, the results of  
which factor into the residency match. 
“The Washington University directors 
have developed novel approaches that 
serve as a fantastic model for those of  
us around the country teaching commu-
nication skills to our students,” said  
Lisa Bernstein, MD, FACP, associate 
professor of medicine and director of 
Becoming a Doctor curriculum at Emory 
University School of Medicine. Bernstein 
also served on an NBME communication 
skills task force. 
said Reggi, an actor, director 
and producer who trained at 
Second City. “I have to step 
outside of myself, remain neu-
tral and think about how this 
other person would respond. 
Certainly, it’s less random 
than improv, but it still 
requires spontaneity. It’s  
where art and science meet.”
Program facilitators design simulated cases that 
reect the region’s actual patient population, 
deriving input from clinical faculty, and build-
ing in elements of religious, ethnic and economic 
diversity. ey strive to promote the use of appro-
priate, inclusive language and create scenarios  
that may be outside of the students’ comfort zone, 
such as a same-sex couple seeking treatment for  
an adopted child. 
e students are given a host of increasingly 
dicult scenarios each year. In their second year, 
students simulate an evolving physician-patient 
relationship by visiting the same SP multiple 
times. ird-year students participate in special-
ized SP encounters during rotating clerkships. 
 “e idea is that the more robust you make  
the practice environment, the more powerful  
and richer the insights,” Glueck said. 
 “Students bring innate abilities of varying 
degrees,” added Alan I. Glass, MD, assistant 
vice chancellor and director of Habif Health 
& Wellness Center. As a clinical skills section 
leader for rst- and second-year students,  
Glass works closely with the SP program. 
“For some students, it’s very easy,” Glass said. 
“For others — like in any subject — it takes 
more eort. We can teach them skills to be  
more eective.”
Glueck cautions, however, it’s not about  
making students all the same. It’s about helping 
students discover their individual styles so  
they can communicate in a way that feels  
natural and genuine.
“Over the course of time, we have a record of 
multiple patient encounters, and footage of them 
interacting with dierent people,” Glueck said. 
“We use this to see where students are struggling 
and translate this into actionable steps we can 
work on together so they can become the kind  
of doctor they want to be.”
Having gone through the entire SP program, 
fourth-year student Phillip McGuiness feels he is 
ready to face the real thing. “Much of the mental 
acrobatics, the awkwardness, is gone. e stan-
dardized patients just take it all in stride. ese 
professionals have played a big part in making 
me a more ecient, compassionate doctor.”
High-tech eavesdropping 
with a purpose: Alan I. Glass, 
MD, watches and listens as  
a student group interacts 
with a standardized patient.
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Examining “bedside manner” “ S OME  WILL  SAY  SPs don’t 
make up for real patients, which 
is true. Our students still round 
on hospital patients, but this 
gives them a focused, observed 
opportunity to practice. Self-
assessment is critical to lifelong 
learning.” — ALISON WHELAN, MD
orn
141286_StandPat_10-14_CS6.indd  14 4/2/14  3:59 PM
outlook.wustl.edu Outlook  15
Taylor Family Institute For 
Innovative Psychiatric Research
psychiatry ’s 
Partnership envisions  
novel treatments  
for mental illness
therapeutic frontier
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A new day may be dawning.  anks to a visionary 
$20-million gi from Andy and Barbara Taylor and the 
Crawford Taylor Foundation, the School of Medicine now  
is home to the Taylor Family Institute for Innovative 
Psychiatric Research. Established in fall 2012, the institute 
seeks to advance the science underlying the diagnosis  
and treatment of psychiatric illnesses. 
Historically, the School of Medicine has led the eld of bio-
logical psychiatry and was among the earliest to dene mental 
illness as a disease, not a character aw — one that could  
be investigated in the same way as cancer or heart disease. 
e institute unites basic and clinical researchers from 
several medical school departments. Together, the investiga-
tors bring complementary skills and interests ranging from 
medicinal chemistry to animal behavior. 
 “Our main objective is to nd new treatment targets in 
hopes of developing more eective drugs,” said Zorumski, 
the institute’s director. 
Scientists do not yet understand the mechanisms causing 
psychiatric illnesses, but Zorumski said it is clear they can-
not be explained solely as chemical imbalances, as once was 
thought. “Neurochemistry may be involved, but there are 
many pathways to explore,” he said.
Psychiatric drugs today oen treat symptoms. Instead, the 
institute is looking at new therapies to alter the brain networks, 
or circuitry, associated with psychiatric disorders. It’s these 
networks that are involved in the symptoms of the illnesses.
“Our current view is that major psychiatric illnesses 
reect dysfunction in the brain networks that underlie  
cognition, emotion and motivation,” Zorumski said.  
Specically, cognition refers to how people think, perceive 
and remember. Emotion is how people attach meaning, and 
motivation is how people set and work toward goals. ese 
processes, which work through various neural pathways that 
have yet to be fully understood, oen are impaired in mental 
illness. “e key is to nd treatments (pharmacological  
and psychotherapeutic) that modify dysfunctional neural 
circuits,” he said. 
There is shared circuitry among psychiatric disorders, 
although specic illnesses may involve dierent parts of this 
circuitry. For example, changes in the hippocampus, a brain 
region involved in memory processing, occur in schizophre-
nia, depression and post-traumatic stress disorder. Yet, how 
this region is involved may dier among the disorders.
 Schizophrenia, for instance, signals a breakdown in 
thinking and poor emotional responses. It involves three 
PS Y C H I A T R I C  D I S O R D E R S  A F F E C T more than 80 million Americans, disrupting their ability to cope with daily living. Le 
untreated, the individual and societal costs are 
staggering — including disability, unemployment, 
substance abuse, physical illnesses, family discord, 
homelessness, incarceration and suicide.
Despite the prevalence of psychiatric problems, 
there are relatively few eective drugs for treating 
them. Even the best drugs are limited, treating a 
portion of a person’s symptoms, and many cause 
side eects. Novel pharmacological targets remain 
the best hope for diminishing the major public 
health impact of psychiatric illnesses, but drug 
makers have largely abandoned the eort following 
failed clinical trials. Development, they have  
determined, is too risky and expensive.
Current antidepressants, antipsychotics and 
anti-anxiety drugs remain largely unchanged  
from past decades. Newer modications might  
be safer or more tolerable, but a truly innovative 
drug hasn’t been discovered for 30 years. 
“Most of the drugs used today focus on the  
same molecular targets in the brain as drugs  
that were used in the 1950s and ’60s,” said Charles 
Zorumski, MD, the Samuel B. Guze Professor 
of Psychiatry and Neurobiology and head of the 
Department of Psychiatry. 
taylorfamilyinstitute.wustl.edu
Learn more about the institute:
Washington University    School of MedicineInnovative collaborations
Ten investigators with six labs in four 
departments will pursue drug discoveries, 
novel therapeutics, lifestyle interventions,  
and partner with clinical affiliates
Drug  
discovery/ 
synthesis
Biochemical  
testing
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types of symptoms: positive, meaning additional symptoms 
most people do not typically experience, such as delusions 
and hallucinations; negative, meaning symptoms reecting 
deciencies, such as social withdrawal and an inability to 
express emotions; and cognitive, meaning problems with 
attention, language and short- and long-term memory. 
Current therapies treat schizophrenia’s positive symp-
toms, but do virtually nothing for the negative or cognitive 
symptoms, which hamper one’s ability to function in a job or 
relationship. us, investigators are looking for treatments 
that could address these cognitive and negative symptoms. 
Initial  research focuses on neurosteroids and oxysterols, 
naturally occurring, cholesterol-derived brain chemicals  
that may help regulate cognition, emotion and motivation. 
Stress, the evidence shows, diminishes neurosteroid  
production; decreased neurosteroid levels are linked to 
depression, anxiety, alcoholism, epilepsy and Alzheimer’s, 
among other disorders. 
Replacing these depleted levels with synthetic neuroactive 
steroids may help alleviate the altered stress responses and 
allow the brain to function more normally. 
Researchers are working to identify neurosteroids and 
oxysterols in the brain, how they are made and how they 
bind to cell receptors. ey are studying natural and syn-
thetic versions of these molecules not only as psychiatric 
treatments, but also as potential anesthetics. 
Although the Taylor Family Institute is new, decades of 
prior collaborations brought researchers national recognition 
for neurosteroid, neuronal function and anesthesia research.
“We were mostly trying to learn about the anesthetic 
eects,” said Douglas F. Covey, PhD. “Now, we’re also looking 
at how those molecules might inuence psychiatric health.”
Covey, a medicinal chemist and professor of pharmacol-
ogy in developmental biology, dedicates his career to identify-
ing natural and designing synthetic neurosteroid molecules. 
Hexagonal drawings mark notebooks, countertops and the 
glass-covered hoods where the molecules are made in his lab.
Covey and his team have built a library of more than 
700 compounds. Pointing to a large le cabinet, he half-
kiddingly explained that the molecules documented in those 
drawers may be good candidates for anesthetics. It’s possible, 
he said, that some of the therapies being sought by Taylor 
Institute scientists for mental illness already exist there.
Transforming a synthetic molecule into treatment 
requires signicant resources. Taylor Family Institute sci-
entists are excited about a partnership with Massachusetts-
based SAGE erapeutics, which develops medicines for 
central nervous system disorders. SAGE could quickly move 
promising therapeutic molecules into clinical trials, and 
already has licensed the contents of Covey’s le cabinet. 
Institute scientists also are studying potential treatments 
developed elsewhere. “e anesthetic drug ketamine may 
have the potential to alleviate depression in some patients 
with a treatment-resistant form of the disorder,” Zorumski 
said. “We’re testing that now, and we will investigate  
other novel therapies. 
“e eld of psychiatry has been doing the same things 
over and over again with the same result. We think it’s  
time to try a new approach.”
In a recent Journal of Neuroscience article, School of 
Medicine researchers explained how, in animal models, oxy-
sterols modulate cell receptors involved in learning and mem-
ory. ese receptors dier from those targeted by current 
medications and so they could be useful in the development  
of new drugs. “Whether oxysterols are involved in the biology 
of schizophrenia is an unanswered question,” Zorumski said. 
“Regardless, oxysterols may represent a new approach to 
improve brain function in patients with mental disorders.”
 Similar considerations can be made for neurosteroids, 
which help control how neurons respond to stressors in 
the brain. By modulating function of key brain networks, 
neurosteroids could serve as eective treatment strategies  
in a variety of disorders. 
1. David Wozniak, PhD; 2. David Reichert, PhD; 3. Charles Zorumski, MD;  
4. Alex Evers, MD; 5. Douglas Covey, PhD; 6. Joe Henry Steinbach, PhD;  
7. Gustav Akk, PhD; 8. Ziwei Chen, PhD; 9. Yuki Izumi, MD, PhD; and 
10. Steven Mennerick, PhD. 
Washington University    School of Medicine Neuroscience Products Company
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STR    KE!
Expediting response  
and treatment
P H Y S I C I A N S  T O D A Y  K N O W  
that time makes all the difference when it comes  
to stroke. 
The brain is unforgiving to lack of oxygen.  
Without it, 1.9 million brain cells die every minute.  
But with prompt treatment, significant disability 
can be minimized. Hence, “time is brain” now is a 
nationally recognized stroke awareness campaign.
Leading School of Medicine specialists have 
worked vigilantly to beat the clock. As a result, 
patients seen at the Washington University and 
Barnes-Jewish Stroke & Cerebrovascular Center  
have improved outcomes and are given the best 
chance for survival and recovery. 
The multidisciplinary team provides some of  
the fastest stroke critical care in the U.S. —  
assembling in the Emergency Department within 
minutes and bringing deep resources to the high-
stakes task of stroke diagnosis and treatment. 
Further, School of Medicine physicians are  
helping to shape treatment regionally and  
nationally as they define and propose time-critical 
standards and continue to pioneer methods of 
evaluating and managing stroke.
Spring 201418  Washington University School of Medicine
B Y  D E B  P A R K E R
Accelerating the 
         critical countdown
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and treatment
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More time elapses,  
more brain tissue dies.  
Urgent treatment could  
still limit the disability.
Some brain regions  
(red) already are 
irreversibly lost.
The window is  
closing. Treatment at 
this time may result in  
moderate disability.
Without treatment,  
all at-risk tissue has died; 
the unfortunate result 
may be severe disability.
10minutes 1hour 3hours 6hours
EMERGENC Y IN MOTION:  
Medical personnel participate in a  
training exercise for transporting  
a stroke patient to the Washington 
University and Barnes-Jewish  
Stroke & Cerebrovascular Center.
Following stroke onset,   at-risk brain regions  could be revived with prompt treatment.
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Decreasing door-to-needle times
Washington University physicians at Barnes-Jewish treat 
1,600 strokes annually, with four to 10 suspected stroke 
patients arriving each day. Despite these high volumes, the 
stroke center has achieved one of the fastest “door-to-needle” 
averages in the country. 
“Door to needle” (D2N) is the 
time between the patient’s arrival 
at the hospital and IV administra-
tion of the clot-dissolving drug 
tPA (tissue-plasminogen activator). 
e drug widely is considered the 
best course of action in an isch-
emic stroke, when a clot cuts o 
blood ow to parts of the brain.
Ideally, the drug should be 
delivered within 60 minutes of 
stroke onset, the so-called “golden 
hour.” If tPA is given within 
three hours of an ischemic stroke, 
one in three patients will benet 
and, within 4.5 hours, one in six 
patients will benet. 
A patient’s maximum decit, 
such as paralysis on one side of 
the body or slurred speech, happens at the time of stroke 
onset when a brain region is starved for oxygen. If blood is 
restored quickly, these eects essentially can be undone.  
e longer it takes to administer treatment, the more likely 
the patient will suer permanent consequences.
Nationally, the average D2N time is as high as 80 minutes, 
according to the American Stroke Association. Today, the 
D2N median at Barnes-Jewish Hospital is 39 minutes, with 
many patients receiving tPA in 20 minutes or less. e next 
goal is to sustain a 30-minute median. 
Stroke’s critical timeline
COMMUNITY GENERAL
Hemorrhagic    A brain artery ruptures
Ischemic    Clot blocks blood flow
Most strokes (80% or more) are ischemic
Brain cells need constant nourishment to survive; it’s delivered by blood via  
the arteries. When blood flow is disrupted, myriad cells begin dying, short- 
circuiting vital functions. Soon, the person may no longer be able to see,  
speak or function in familiar ways.
Seconds count— from the moment of stroke onset, to the 
arrival of emergency personnel, through transport to a 
hospital. Expertise, equipment and enhanced protocols make 
a certified stroke center the destination of choice, even at a 
D2N
TI
M
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BJH D2N  
median is  
39 minutes,
but often  
20 minutes 
or less
Front door to ED doorA crisis within
Transforming a complex process
How does a broadscale team — involving emergency medi-
cine physicians, neurologists, neurosurgeons, radiologists, 
interventional neuroradiologists and dozens of ancillary  
sta — become that nimble?
In 2010, the median D2N time in the Barnes-Jewish 
Emergency Department (ED) was 55 to 60 minutes, but the 
stroke team determined it could do better by applying lean 
manufacturing principles developed by the Japanese car 
manufacturer Toyota. 
Team members met for two days with lean engineers to 
examine each of the 50-plus steps leading to tPA administra-
tion. Each step — from patient registration and vital signs 
The national 
average exceeds 
one hour
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monitoring to labs and imaging — was evaluated from an 
eciency perspective. e objective was to reduce bottle-
necks, improve teamwork and communication and ensure 
that those caring for patients have easy access to supplies  
and equipment.
 “We sought suggestions from everyone involved, from 
the paramedics who bring in patients, to admitting clerks, 
radiology technologists, nurses and physicians,” said Jin-
Moo Lee, MD, PhD, senior author of the study that was pub-
lished in Stroke. Lee is a Washington University neurologist 
at Barnes-Jewish Hospital and director of the Department  
of Neurology’s cerebrovascular disease section. 
e complex treatment process could be streamlined,  
they decided — even before patients arrive at the hospital. 
Activating the stroke team en route
In the past, emergency medical services (EMS) personnel 
brought the patient to BJH and clinicians there determined 
whether the person was having a stroke. 
Paramedics now alert BJH sta when a potential stroke 
patient is en route. An immediate page goes out to stroke 
team members who are ready and waiting when the ambu-
lance or helicopter arrives. EMS partners are well trained and 
fully entrusted to activate the team. “One thing we’ve learned 
is that you have to cast a very wide net,” Lee said. “We have  
a very liberal policy for stroke pager activation. For every 
eight activations, only one is treated with tPA. It’s a lesson  
to learn: capture as many as you can and consider all  
potential candidates.”
Using clinical scales, EMS workers can determine the 
severity of a stroke. ey also can lower a patient’s high  
blood pressure en route, making tPA treatment a more  
viable option.
And to help determine time of stroke onset, which is  
critical when evaluating treatment options, EMS crews will 
begin a new practice: leaving calling cards with witnesses, 
encouraging them to contact the stroke team with more details. 
STROKE CENTER
Stroke teams seek to compress the time until treatment begins. Parallel processing 
— in which team members work simultaneously to perform a variety of tasks — 
facilitates this race against the clock. Innovative approaches to practical problems 
help deliver treatment in 30 minutes or less in some cases.
Members of the stroke team and specialty areas: (back row, from left to 
right) Renee B. Van Stavern, MD, (neurology); David A. Carpenter, MD, 
(neurology); Gregory J. Zipfel, MD, (neurosurgery and neurology);  
Colin P. Derdeyn, MD, (neuroradiology, neurology, neurosurgery);  
and Andria L. Ford, MD, (neurology); and (front row) Peter D. Panagos, 
MD, (emergency medicine and neurology); and Jin-Moo Lee, MD, PhD, 
(neurology and radiology).
Reinventing stroke care
farther distance. However, when patients cannot make 
the journey, Washington University stroke physicians 
partner with community hospitals in critical care 
decisions, using telemedicine (see page 23).
Door to needle
t
P
A
Front door to ED door
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Acute stroke team members converge  
at the CT scanner upon patient arrival;  
ED nurses respond with carefully 
choreographed, pre-planned routines.
Emergency medical transport leader conveys patient 
information to stroke team physicians; physicians 
perform rapid neurological tests, assessing lab results 
and responding with real-time decisions.
Patient is stabilized and ready for a brain 
scan and its immediate review by physicians. 
Intravenous drip is in place and ready to 
administer therapeutic drug.
TEAMWORK COMMUNICATION, ANALYSIS, DECISIONS DATA & DRUG DELIVERY
Working in concert
Previously, suspected stroke patients rst were taken to a 
trauma bay for history taking, blood draw and neurological 
exam. From there, they were transported to an ED-dedicated 
CT scanner to determine whether the stroke was ischemic  
or hemorrhagic (ruptured artery), before being taken back  
to the trauma bay for further assessment. 
Based on recommendations of the process improvement 
team, paramedics now sidestep the trauma bay and take the 
patient directly to the CT scanner for prompt evaluation. 
“We can obtain the story, begin the neurological exam, 
initiate patient registration, complete the brain imaging 
within minutes — all in the CT scanner room — quickly 
determining if the patient meets tPA criteria,” said Peter D. 
Panagos, MD, associate professor of emergency medicine 
and neurology. “Eliminating these extra steps saves 12  
to 15 minutes.” 
Using parallel processing, steps previously performed 
in sequence are carried out simultaneously with additional 
sta. Every team member has a role that is not duplicated. 
Instituting lab tests that could be performed at the bedside 
reduced time spent waiting for results.  
Meanwhile, interventional radiologists are on standby  
for patients who do not respond to tPA. ese patients may  
benet from endovascular interventions using tools that  
can retrieve clots or open arteries in other ways. In the past 
few years, these devices have shown great improvement, 
according to Colin P. Derdeyn, MD, professor of radiology  
and director of the stroke and cerebrovascular center.
Improving patient outcomes
Following months of renement, 78 percent of patients now 
are treated within “the golden hour” — up from 52 percent 
— and team members continue to speed the process. 
“is is only one of our lean process success stories,” Lee 
said, “but it nicely demonstrates how lean transformation 
can improve processes across the spectrum of stroke care.” 
Aer the patient is admitted to the hospital, the team 
puts much of its emphasis on preventing life-threatening 
complications and determining why the stroke occurred  
in the rst place, taking steps to prevent the high risk  
of recurrence. For instance, as atrial brillation is a  
common stroke trigger, the patient may be placed on  
an anticoagulant. 
Orchestrating a precision “parallel response”
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Striving toward personalized care
Remarkably, School of Medicine researchers are beginning 
to suggest that some of those patients who miss the optimal 
three-hour treatment window may still have hope. In limited 
cases, physicians here are, in eect, throwing out the clock.
“Every stroke case is dierent,” Lee said. “Some patients 
may have just enough blood ow to preserve brain tissue — 
even aer six hours. Other patients might not have viable 
brain tissue aer one hour.” Future technologies may pro-
vide a more sophisticated determinant.
Lee is leading a study searching for new methods to 
image and identify salvageable tissue. 
Oxygen metabolism is a good indicator of brain viability. 
Lee and Andria Ford, MD, assistant professor of neurology, 
devised a quantitative map of oxygen metabolic index (OMI) 
viewable on MR scans. As OMI drops, there is a threshold  
at which brain cells will stop working but may still be alive, 
and another threshold past which tissue is dead. is initia-
tive is based on the theoretical work of radiology professor 
Dmitriy Yablonskiy, PhD, and performed in close collabora-
tion with Weili Lin, PhD, and Hongyu An, DSc, at the 
University of North Carolina-Chapel Hill.
Initial results suggest this six-minute scan accurately 
highlights brain areas that may survive if successfully 
reperfused. Knowing this would allow stroke teams to more 
eectively determine the appropriate course of action —  
tPA, interventional radiology — or perhaps some treatment 
that hasn’t yet been developed. 
“It’s all about providing the right care to the right  
patient at the right time,” Lee said. 
In 2013, Barnes-Jewish became the first compre-hensive stroke center in 
Missouri and among the  
earliest in the country. 
The Joint Commission 
and the American Heart 
Association/American Stroke 
Association established the 
advanced certification to rec-
ognize hospitals that achieve 
higher standards and meet 
criteria for resources, staff and 
training essential to treating 
the most complex stroke cases. 
Comprehensive stroke centers 
provide the full spectrum of 
care, from diagnosis to spe-
cialized rehabilitation. David 
A. Carpenter, MD, associate 
professor of neurology, directs 
Barnes-Jewish Hospital’s com-
prehensive stroke center.
Missouri’s Time-Critical 
Diagnosis statute dictates that, 
in the same way car crash vic-
tims must be taken to trauma 
centers, stroke patients now 
must be taken to certified 
stroke centers, sometimes 
bypassing closer hospitals. 
Time lost in transit might 
be made up with resources 
and expertise. Washington 
University faculty members 
were key in crafting this leg-
islation; several sit on state 
review boards, traveling to 
various hospitals to evaluate 
their processes.  
The team shares best  
practices and, through web-
based communications, 
conducts real-time patient 
assessments with regional 
emergency departments, par-
ticularly those in rural counties 
that may have no immediate 
access to neurologists or other 
specialty physicians. 
Some hospitals are not 
equipped to administer tPA 
or make acute-care decisions; 
others can administer tPA and 
transfer patients to compre-
hensive stroke centers. Because 
of these collaborations, some 
hospitals previously bypassed 
by paramedics now are 
equipped to deliver care for 
milder strokes, while severe 
strokes still are best served  
at comprehensive centers. 
 “This is about how you 
can impact remote communi-
ties with a collective effort,” 
Lee said. “This major push has 
made all the difference. Time-
critical diagnosis has prompted 
us to rethink how we handle 
regional patient flow.” 
Seeing ways to save more brain
Reaching beyond the hospital
Nearly two hours
after a stroke
Six hours
and counting
One month  
afterward
Advanced MR images indicating oxygen metabolism levels in the 
brain (red indicates the highest level) show promise for facilitating 
faster, better-informed and more precise stroke treatment decisions. 
A massive brain region 
(left) starves for oxygen; 
restoring blood flow 
could prevent severe 
permanent disability.
A clot-busting drug 
therapy successfully 
restores oxygenated 
blood to all but the 
encircled region.
The area of permanent 
damage corresponds to 
the high-risk region that 
was shown by the six- 
hour metabolism scan.
Renee B. Van Stavern, MD, above, and Peter Panagos, MD, lead the  
stroke center’s telemedicine network with regional hospitals.
The stroke center’s  
patients originate  
from 100 hospitals  
in 7 states.
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matchday
ON MARCH 21, graduating medical students at Washington University opened envelopes revealing where they will spend the next 
years training in their chosen specialty. During 
Match Day, held annually in March, thousands of 
fourth-year medical students across the U.S. simul-
taneously learn their results from the National 
Resident Matching Program. School of Medicine 
graduates are highly successful in obtaining  
24  Washington University School of Medicine Spring 2014
A L A B A M A
Birmingham
University of Alabama  
Medical Center 
I N T E R N A L  M E D I C I N E
Lauren Kelly Shea
A R I Z O N A
Phoenix
St. Joseph’s Hospital/ 
Barrow Neurological Institute
N E U R O L O G I C A L  S U R G E R Y
Jakub Godzik
C A L I F O R N I A
Camp Pendleton
Naval Hospital Camp Pendleton
F A M I LY  M E D I C I N E
Jennifer Mae Jupitz
Irvine
University of California– 
Irvine Medical Center
I N T E R N A L  M E D I C I N E
Miriam Shugufa Nojan
Los Angeles
Harbor–UCLA Medical Center
I N T E R N A L  M E D I C I N E
Nichelle Megowan
San Diego
Scripps Mercy Hospital
I N T E R N A L  M E D I C I N E 
Nilika Chaudhary
San Francisco
University of California–  
San Francisco
G E N E R A L  S U R G E R Y
Jhoanne Lynne Bautista
I N T E R N A L  M E D I C I N E  
P R I M A R Y
Elisabeth ames Boehme  
 Askin
Elaine Ching-Feng Khoong
O T O L A R Y N G O L O G Y
Philip Laurence Perez
PAT H O L O G Y
Gregory Richard Bean
Stanford
Stanford University Program 
A N E S T H E S I O L O G Y
Francesca Betti
PAT H O L O G Y
Ansuman Satpathy
C O L O R A D O
Denver
Denver Health Medical Center
E M E R G E N C Y  M E D I C I N E
Robert Jared Klemisch
C O N N E C T I C U T
New Haven
Yale–New Haven Hospital
G E N E R A L  S U R G E R Y
Raymond Alexander Jean
O P H T H A L M O L O G Y
Jenna May Kim
F L O R I D A
Miami
Jackson Memorial Hospital
A N E S T H E S I O L O G Y
Paul Scott McNair
I N T E R N A L  M E D I C I N E
Nhi Hoai Nguyen
G E O R G I A
Atlanta
Emory University  
School of Medicine
E M E R G E N C Y  M E D I C I N E
Akshay Ganju
P S Y C H I AT R Y
Georgina Elizabeth Hartzell
Morehouse School of Medicine
G E N E R A L  S U R G E R Y  
P R E L I M I N A R Y
Michael Brandon Williams
I L L I N O I S
Chicago
Rush University Medical Center
O P H T H A L M O L O G Y
Afua Helen Annor
Schwab Rehabilitation Hospital
P H Y S I C A L  M E D I C I N E  A N D 
R E H A B I L I T AT I O N
Vovanti Tivoli Jones
University of Chicago  
Medical Center
I N T E R N A L  M E D I C I N E
Mary Clare Masters
P E D I AT R I C S
Leena Vikas Padhye
R A D I AT I O N  O N C O L O G Y
Sandeep Ramesh Bhave
University of Illinois  
College of Medicine
G E N E R A L  S U R G E R Y
Braden Noah Juengel
L O U I S I A N A
Shreveport
Louisiana State University  
Health Sciences Center
O T O L A R Y N G O L O G Y
Zao Yang
M A S S A C H U S E T T S
Boston
Beth Israel Deaconess  
Medical Center
I N T E R N A L  M E D I C I N E
Philip Scott Kemp
Lauren Margaret Yang
OBSTETRICS AND GYNECOLOGY
Jennifer Chu
Brigham & Women’s Hospital
E M E R G E N C Y  M E D I C I N E
Rittik Chaudhuri
I N T E R N A L  M E D I C I N E
David Morton Rubins
I N T E R N A L  M E D I C I N E  
P R I M A R Y
Ryan Everett Anderson
N E U R O L O G Y
Illya Tolokh
PAT H O L O G Y
Kristine Shannon Wong
Boston Children’s Hospital 
P E D I AT R I C S
Alexandra Hathaway Baker
Harvard Longwood Psychiatry
P S Y C H I AT R Y
Elizabeth Fenstermacher
Massachusetts General Hospital
A N E S T H E S I O L O G Y
Albert Mao
D I A G N O S T I C  R A D I O L O G Y
Ravi Gottumukkala
Gary Xiaoshi Wang 
G E N E R A L  S U R G E R Y
Charles Gerard Rickert
I N T E R N A L  M E D I C I N E  
P R I M A R Y
Christopher Tsung-jer Chen
PAT H O L O G Y
Athena Lee Chen
P S Y C H I AT R Y
Erin Elizabeth Dowd
Tufts Medical Center
O R T H O PA E D I C  S U R G E R Y
Georey Evan Stoker
M A R Y L A N D
Bethesda
National Institute of Mental Health
P O S T D O C T O R A L  F E L L O W S H I P
Jonathan David Power
M I C H I G A N
Ann Arbor
University of Michigan Hospitals
E M E R G E N C Y  M E D I C I N E
Arun Ganti
PAT H O L O G Y
Stephanie Lynn Skala
Royal Oak
Beaumont Health System
O B S T E T R I C S  A N D  G Y N E C O LO G Y
Lauren Elizabeth Perlin
M I S S O U R I
St. Louis
Barnes-Jewish Hospital
A N E S T H E S I O L O G Y
Jacob Martin Basak
Kyle Glenn Jacobsen
Nisha Jain
D E R M AT O L O G Y
Lu Chen
Rachel Lea Kyllo
May Meishu Zhang
D I A G N O S T I C  R A D I O L O G Y
Marina Igorevna Mityul
Ryan P. Rimer
E M E R G E N C Y  M E D I C I N E
Stephanie Kae Charshaan
G E N E R A L  S U R G E R Y
Linda Xiaobo Jin
Jared Michael McAllister
competitive training programs. e largest contin-
gent will continue training locally: Twenty-eight 
at Barnes-Jewish Hospital and two at St. Louis 
Children’s Hospital. e next largest group is 
headed to Harvard Medical School. Of the class,  
31 graduates will train in internal medicine,  
followed by nine each in pediatrics and general 
surgery, eight in emergency medicine and seven 
each in anesthesiology and pathology. 
e next stage
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I N T E R N A L  M E D I C I N E
Amit Indra Bery
Jacqueline Wenjia Chen
Raymond Bamvi Fohtung
Catherine Teresa Jordan
Niall Prendergast
Samuel Wayne Reinhardt
Joshua Michael Saef
Michael Edward Tang
Peter Hou Yu Yen
Kevin Zheng Yuan
N E U R O L O G Y
Osvaldo Jose Laurido-Soto
OBSTETRICS AND GYNECOLOGY
Lucy Liu
O R T H O PA E D I C  S U R G E R Y
Melissa Anderson Wright
P S Y C H I AT R Y
Sarah Elizabeth Jeann 
Donaldson
R A D I AT I O N  O N C O L O G Y
Lauren Elizabeth Henke
U R O L O G Y
Joseph B. Song
St. Louis Children’s Hospital
P E D I AT R I C S
Stephen Charles Gradwohl II
Hallie Faryn Morris
Washington University  
School of Medicine
O P H T H A L M O L O G Y
Cynthia Lee Montana
N E W  H A M P S H I R E
Lebanon
Dartmouth-Hitchcock  
Medical Center
D I A G N O S T I C  R A D I O L O G Y
Ellen Yulin Chang
N E W  M E X I C O
Albuquerque
University of New Mexico  
School of Medicine
E M E R G E N C Y  M E D I C I N E
Heather Nicole Orth
PAT H O L O G Y
Andrew Warren Judd
N E W  Y O R K
New York
Hospital for Special Surgery
O R T H O PA E D I C  S U R G E R Y
Jerey Gei-Hun Stepan
Icahn School of Medicine/ 
Mount Sinai
O T O L A R Y N G O L O G Y
Katelyn Andrea Ostendorf
New York Presbyterian Hospital–
Columbia
I N T E R N A L  M E D I C I N E
Nicholas A. Hoerter
New York Presbyterian Hospital–
Weill Cornell Medical Center
I N T E R N A L  M E D I C I N E  
R E S E A R C H
Agata Agnieszka Bielska
N E U R O L O G Y
Radhika Jagannathan
New York University  
School of Medicine
G E N E R A L  S U R G E R Y
Charles Robert Hong
I N T E R N A L  M E D I C I N E
Aram Kim
O H I O
Cincinnati
Cincinnati Children’s Hospital
P E D I AT R I C S
Mahil Rao
Cleveland
Case Western/Metro Health  
Medical Center
OBSTETRICS AND GYNECOLOGY
Stephanie Rose omas
Case Western/University  
Hospitals
P L A S T I C  S U R G E R Y
Yuewei Wu-Feinberg
Columbus
Ohio State University  
Medical Center
E M E R G E N C Y  M E D I C I N E
David Christopher Harris
O R E G O N
Portland
Oregon Health and Science 
University
O P H T H A L M O L O G Y
Iris Lee
Brigid Kathleen Marshall
P E N N S Y L V A N I A
Philadelphia
Hospital of the University  
of Pennsylvania
F A M I LY  M E D I C I N E
Michael J. Scott
G E N E R A L  S U R G E R Y
Victoria Merrill Gershuni
I N T E R N A L  M E D I C I N E
Allison Jan Steinmetz
N E U R O L O G Y
Laura Esther Mainardi 
Villarino
U R O L O G Y
Marshall Channing Strother
Scheie Eye Institute
O P H T H A L M O L O G Y
Iga Natalia Wegorzewska
Pittsburgh
University of Pittsburgh  
Medical Center
A N E S T H E S I O L O G Y
Diana Souza DeAndrade
PAT H O L O G Y
omas Michael Pearce
P E D I AT R I C S
Michael C. Verre
P O S T D O C T O R A L  P O S I T I O N
Jordan John Williams
S O U T H  C A R O L I N A
Charleston
Medical University of  
South Carolina
P S Y C H I AT R Y
Alton Cleotha Williams III
T E N N E S S E E
Nashville
Vanderbilt University  
Medical Center
P E D I AT R I C S
Andrea Nicole Lambert
T E X A S
Dallas
University of Texas  
Southwestern Medical School
I N T E R N A L  M E D I C I N E
Rabia Salman Akhtar
Usman Akhtar
P E D I AT R I C S
Rachael Celeste Johnston
Houston 
Baylor College of Medicine
C H I L D  N E U R O L O G Y
Ariel Maia Lyons-Warren
E M E R G E N C Y  M E D I C I N E
Matthew Terrence Humbert
I N T E R N A L  M E D I C I N E
Sara Xu Chen
San Antonio
University of Texas  
Health Science Center
O B S T E T R I C S A N D G Y N E CO LO G Y
Brittanie Broersma
U T A H
Salt Lake City
University of Utah  
Affiliated Hospitals
P E D I AT R I C S
Sarah Nicole Cilvik
W A S H I N G T O N
Seattle
University of Washington  
Affiliated Hospitals
I N T E R N A L  M E D I C I N E  
P R I M A R Y
Phillip Andrew McGuiness
N O R W A Y
Oslo
University of Oslo
OBSTETRICS AND GYNECOLOGY
Heidi Elisabeth Fjeldstad
MD/PhD student Radhika Jagannathan learned 
she will be going to New York Presbyterian 
Hospital–Weill Cornell Medical Center. Moments 
later, she received a surprise marriage proposal 
from her longtime boyfriend, Tom Wilson. 
Jacqueline Chen, left, and Linda Jin are staying 
in St. Louis: Both will train at Barnes-Jewish 
Hospital in internal medicine and general  
surgery, respectively.  
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Competitive 
Bhangra dancer 
Ravi Gottumukkala 
celebrates; he  
is headed to  
Massachusetts  
General Hospital.
141286_Matchday_24-25_CS6.indd  25 4/2/14  4:39 PM
classnotes
1940 S 
James Read, MD 43, HS 44, is retired and 
living in New Jersey. His hobbies include 
sketching and drawing classes, swimming 
and croquet. Read is a member of the 
health-care committee for the retirement 
community where he resides. He has been 
honored for philanthropic initiatives and 
helping oversee conditions and issues of 
the retirement community.
1950 S 
John Denman, MD 52, is retired from 
active practice, but still spends time in the 
medical community as a medical school 
volunteer and as president of a retired 
physicians’ group. He plays clarinet in a 
local band; other hobbies include tennis 
and golf. Denman loves spending time 
with his children and grandchildren.
Paul DeBruine, MD 59, is a retired anes-
thesiologist and a trustee emeritus of 
the Elmhurst College Board of Trustees. 
Elmhurst College, DeBruine’s undergradu-
ate institution, awarded him an honorary 
Doctor of Science at its 142nd commence-
ment exercises in June 2013.
1960 S 
Lynn Rosenstock, MD 63, is retired, but 
stays active as a voluntary clinical pro-
fessor of anesthesiology at Stanford 
University School of Medicine. She volun-
teers weekly at a free clinic for the working 
poor, at her local library and on the board 
of the local League of Women Voters.
Charles Shaeffer, MD 64, a cardiologist at 
Eisenhower Medical Center in California, 
was invited to participate in a White 
House briefing on behalf of the American 
Heart Association. With more than three 
decades of service to the AHA, Shaeffer 
has made contributions toward tobacco 
control, obesity prevention and heart dis-
ease and stroke research funding. He has 
been awarded the AHA Gold Heart Award, 
Volunteer Advocate of the Year Award and 
the Jefferson Award Certificate.
Gary Ratkin, MD 67, retired from hematol-
ogy-oncology practice in June 2012 but 
continues to provide leadership to the 
Palliative Care Program at Missouri Baptist 
Medical Center. He also is a volunteer 
physician and medical director at Casa de 
Salud, a low-cost primary care clinic serv-
ing immigrants in the St. Louis area.
1970 S 
Patricia Penkoske, MD 74, was presented 
with Lindenwood University’s Alumni 
Merit Award. She was one of its first grad-
uates to become a physician.
Mark Frisse, MD 78, EMBA 97, is the 
Accenture Professor of Biomedical 
Informatics and director of regional infor-
matics for Vanderbilt University. He was 
elected to the Institute of Medicine in 
2013. Frisse focuses on the intersection 
between health-care informatics, econom-
ics, policy and health-care transformation.
1980 S 
Carol North, MD 83, is serving as president 
of the North Texas Society of Psychiatric 
Physicians and will serve as president 
of the American Psychopathological 
Association in 2015.
Wilson Compton, MD 86, was appointed 
deputy director of the National Institute 
on Drug Abuse, part of the National 
Institutes of Health. Since 2002, he has 
served as director of NIDA’s Division of 
Epidemiology, Services and Prevention 
Research. In 2013, he was one of 10 to 
receive the Health and Human Services 
Secretary’s Meritorious Service Award.
William Powderly, HS 87, the J. William 
Campbell Professor of Medicine, was 
appointed with tenure at Washington 
University School of Medicine. He also 
directs the Institute for Public Health.
1990 S 
David Hunstad, MD 95, was promoted with 
tenure to associate professor of pediatrics 
at the School of Medicine.
2000 S
Betsy Peterson, MD 02, opened a solo 
pediatric practice after residency in 2005. 
Community Pediatrics in Wisconsin now 
has two locations, three pediatricians, 
two pediatric nurse practitioners and 
12 other staff. She also is involved with 
the Wisconsin chapter of the American 
Academy of Pediatrics and was elected to 
the board of directors in 2012. Peterson 
reports that the puppy she got during her 
first year of medical school just turned 15!
Erica Roger, MD 04, HS 08, is a St. Louis 
dermatologist and was the American 
Academy of Dermatology’s Shade 
Structure Grant Program recipient in 2013. 
In Memory 
Joseph Pollock, MD 38, LA 38
 Pollock died Saturday, June 22, 2013, in 
Santa Barbara, Calif., at age 99. After earn-
ing a medical degree, Pollock specialized 
in abdominal surgery, serving as chief 
of surgery at several hospitals, includ-
ing Cedars of Lebanon. He taught at the 
University of Southern California Medical 
School and served as a deputy coroner. 
Besides practicing medicine for almost 
50 years, Pollock ran Triangle Steel and 
Supply and founded, along with his wife, 
Helene, the Music Center of Los Angeles. 
He was active in the Los Angeles County 
Museum of Art and the Mark Taper 
Forum and served as chairman of the 
Santa Barbara International Film Festival. 
Through the Joseph and Helene Pollock 
Foundation, he helped create the Pollock 
Theater at the University of California, 
Santa Barbara.
Marian Green, NU 48
 Green died Saturday, June 22, 2013, in 
Columbia, Mo., at age 85. Green was an 
American Airlines stewardess in the late 
1940s before becoming a registered nurse 
at Barnes Hospital during the 1970s and 
early 1980s. After retirement, she was an 
active member of the Kiwi Club and the 
Kings’ Daughters in Columbia.
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David Kipnis, MD
 Kipnis died Wednesday, Feb. 5, 2014, at 
86. He began his career at WUSM in 1955 
as a research fellow and later was named 
director of the Clinical Research Center 
and Adolphus Busch professor and head 
of the Department of Medicine. During 
his tenure, he established critical links 
between research and patient care, build-
ing collaborations among the Department 
of Medicine and the school’s basic science 
departments. His many achievements 
include overseeing construction of the 
Clinical Sciences Research Building and 
establishing a diabetes and endocrinology 
center at WUSM.  Washington University 
honored Kipnis with Second Century and 
Distinguished Service awards. He also 
received honors from the Association of 
American Physicians, American Diabetes 
Association, Endocrine Society, Institute of 
Medicine, American Academy of Arts and 
Sciences, National Academy of Sciences 
and American College of Physicians. 
Ervin Lipschitz, MD 49, LA 49
 Lipschitz died March 14, 2013. He earned 
undergraduate and medical degrees 
from Washington University, completed 
an internship in internal medicine at 
Barnes Hospital and served as an assistant 
resident in medicine at Jewish Hospital. 
Lipschitz completed a psychiatry residency 
at The Menninger Clinic in Topeka, Kan. 
He practiced medicine from 1949-2010. 
He worked in private practice and as a 
staff psychiatrist at VA Medical Centers 
in St. Louis, as a consulting psychiatrist 
for St. Louis Community College and 
Maryville University and as director of the 
psychiatric services section at Washington 
University Student Health Services. He was 
on the faculty of Saint Louis University and 
Washington University. 
Robert Paine, HS 49
 Paine died Sunday, June 16, 2013. At 
age 16, he attended Harvard University, 
earning bachelor’s and medical degrees 
before moving to St. Louis to complete his 
residency. Paine served in the U.S. Army 
Air Corps during World War II. Afterward, 
he received a Rockefeller fellowship in 
cardiology at the School of Medicine. He 
served as founder and chief of cardiol-
ogy for more than 40 years at St. Luke’s 
Hospital, clinical professor of medicine 
at the School of Medicine, fellow of the 
American College of Physicians and fellow 
of the American College of Cardiology. 
James Adams, MD 55
 Adams died Thursday, May 9, 2013, at 
the age of 83. After training at the School 
of Medicine and serving as a U.S. Army 
captain, Adams taught on the University 
of Rochester faculty for nearly 51 years. As 
a professor of surgery, he cared for many 
patients and trained hundreds of residents 
and medical students. 
Richard A. Lattner, DE 56
 Lattner died Saturday, April 20, 2013, at 
age 83. He practiced dentistry in St. Louis 
for more than 30 years and taught at 
Washington University School of Dentistry 
until his retirement in 1989. Lattner, a com-
mander in the U.S. Naval Reserve, was bur-
ied with full military honors at Ft. Jackson 
National Cemetery in South Carolina.
Robert Christie Wray Jr., MD 63 
Wray died Monday, Nov. 18, 2013. After 
completing medical school, Wray was on 
the faculty at Washington University, the 
University of Rochester School of Medicine 
and the Medical College of Georgia, where 
he was chief of plastic surgery. Wray 
served on the American Board of Plastic 
Surgery, the Western Trauma Association, 
the Association of Academic Chairmen 
in Plastic Surgery and the American 
Association of Plastic Surgeons, holding a 
number of leadership positions.
David Hussey, MD 64
 Hussey died Wednesday, April 17, 2013.  
After earning a bachelor’s degree from 
Beloit College, he attended Washington 
University School of Medicine. He com-
pleted a residency at the University 
of Iowa and a fellowship in radiation 
oncology at the University of Texas M.D. 
Anderson Hospital and Tumor Institute, 
where he was a faculty member until 
1983. He also taught at the University of 
Iowa and the University of Texas Health 
Science Center. Hussey was active in  
several national organizations, including 
the American College of Surgeons and  
the American Board of Radiology. 
Isaac Boniuk, HS 
 Boniuk died Thursday, Aug. 1, 2013. After 
attending Dalhousie University for under-
graduate and medical degrees, Boniuk 
completed an ophthalmology residency at 
the University of California, San Francisco, 
and a retinal fellowship at Barnes Hospital. 
He served as a captain in the U.S. Army 
Medical Corps in Okinawa for two years. For 
38 years, he practiced at Retinal Consultants 
in St. Louis, in addition to publishing many 
articles on clinical ophthalmology research. 
Susan Kennedy, MD 72, HS 76
 Kennedy died Tuesday, July 9, 2013, at the 
age of 65. She earned a bachelor’s degree 
from the University of Oklahoma, before 
attending medical school at Washington 
University. Kennedy owned and operated 
several dermatology clinics in Arizona. 
She was a successful golfer and quali-
fied for the USGA Women’s Amateur Golf 
Tournament in 1964 and 1984.
Robert Burgerman, EN 79, MD 84, HS 85
 Burgerman died Friday, July 12, 2013, 
at age 54. He earned degrees in electri-
cal engineering and medicine from 
Washington University, completed a 
neurology residency and EEG fellowship 
at the University of Maryland, followed by 
an epilepsy fellowship at the University of 
Pennsylvania. Burgerman practiced medi-
cine for 21 years in Sacramento, Calif., was 
founder and medical director of the Sutter 
Comprehensive Epilepsy Program and 
medical director of Sutter Neurodiagnostic 
Laboratories. He was on the medical staff 
at Mercy General Hospital and UC Davis 
Medical Center.
Harvey Saligman
 Saligman died Friday, Nov. 15, 2013, 
at age 75. He was a longtime friend of 
Washington University and served on its 
Board of Trustees for more than 25 years. 
During this tenure, Saligman raised and 
donated millions of dollars for scholar-
ships, new facilities and research at 
Washington University. In 2009, Saligman 
and his wife, Linda, established the Harvey 
and Linda Saligman Multiple Myeloma 
Research Fund, which, in less than five 
years, began yielding results, including 
clinical trials for two new drugs and a large 
myeloma tissue bank for ongoing research. 
Outlook  27outlook.wustl.edu
141286_MAD_26-36_CS6.indd   27 4/2/14   4:48 PM
Spring 201428  Washington University School of Medicine
Together.
Together, we learn.
Together, we discover.
Together, we create.
Together, we heal.
Together, we innovate.
Together, we lead.
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t is a pleasure to report to you on the success to date of 
Leading Together: e Campaign for Washington University. 
We are at the midpoint of the campaign and more than 
halfway to achieving our goal. e response to the campaign 
reects a tremendous condence in the School of Medicine, 
and it positions us well for the remainder of the campaign.  
We are grateful for your generosity.
 ere is no question that every gi matters. Funds 
directed toward research can be strategically applied to 
leverage additional funding from other sources. Seed 
funding for pilot projects that result in proof of concept for 
scientic ideas can position researchers to obtain substantial 
funding from government agencies and corporate sponsors. 
Financial support 
through endowed 
professorships, as 
well as endowed 
fellowships and 
scholarships, is  
critical to retaining 
and recruiting the most important resource of the School  
of Medicine: the extraordinary people who lead the eld in 
teaching and research. 
 We look forward to the second half of the campaign 
and to establishing a new record level of support. Please 
consider participating if you have not done so already, as 
together, we ensure the future success of the School of 
Medicine and its myriad eorts to improve human health.
George W. Couch III   •   David C. Farrell   •   Gordon W. Philpott, MD
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C O M M I T T E E  M E M B E R S
ANDREW CHAN, MD/PhD ’86, HS ’89
Senior Vice President, Genentech 
ROBERT G. CLARK
Chairman and CEO, Clayco Corporation
PETER CORR, PhD
Co-Founder, Auven Therapeutics  
Management LLLP
LOUIS KUCHNIR, PhD, MD ’97, HS
Private Practice Physician 
JAMES S. MCDONNELL III
PHILIP NEEDLEMAN, GR ’99
Emeritus Trustee of Washington University
WILLIAM A. PECK, MD, HS ’63
Director, Center for Health Policy 
Former Dean and Executive Vice Chancellor
SHIRLEY SAHRMANN, PT ’58, MA ’71, PhD ’73, HS
HARVEY SALIGMAN *
Trustee of Washington University
CRAIG D. SCHNUCK
Chairman, Schnucks Markets Inc. 
Trustee of Washington University
SALLY SCHNUCK, OT ’78
LARRY J. SHAPIRO, AB ’68, MD ’71
Executive Vice Chancellor for Medical Affairs  
and Dean, School of Medicine
WILLIAM P. WIESMANN, MD ’72, HS
President and Founder, BioSTAR Group
Trustee of Washington University
PAMELA GALLIN YABLON, AB/BS ’74, MD ’78
Director, Pediatric Ophthalmology,  
Professor of Pediatrics,  
Columbia Presbyterian Medical Center
* Deceased
Together, we learn.
Together, we discover.
Together, we create.
Together, we heal.
Together, we innovate.
Together, we lead.
C A M PA I G N  C O - C H A I R S
GEORGE W. COUCH III
Trustee of  Washington University
DAVID C. FARRELL
Emeritus Trustee of  Washington University
GORDON W. PHILPOTT, MD ’61, HS
Former Chief of Surgery at Jewish Hospital 
Former Trustee of Washington University
I
Making progress through Leading Together:  
e Campaign forWashington University.
* Totals as of Dec. 31, 2013
$713,911,763
Progress toward the campaign goal of $1.1 billion*
Time elapsed during the 112-month campaign
58 MONTHS
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Washington University School of Medicine has an enviable 
record of achievement. We excel in each of our areas of 
endeavor. We have enormous assets in people, facilities and 
reputation. We have a tradition and a culture that places a high 
value on excellence in everything that we do. All of this requires 
signicant nancial resources beyond those currently available. 
is campaign and your participation can tip the balance 
toward achieving even greater success.
Eighteen Nobel Laureates have been associated with 
Washington University School of Medicine. We are world 
leaders in genetics and genomics and their application in the 
development of personalized medicine, specically with regard 
to improving outcomes in cancer care and prevention. We 
have long been leaders in neuroscience and have conducted 
pioneering research in the area of Alzheimer’s disease. We are 
one of the world’s preeminent institutions in the development 
and application of imaging techniques and annually rank 
among the top medical schools in the U.S. in the amount of 
competitively awarded funding that we secure from the  
National Institutes of Health.
However, today there is a conuence of external and internal 
factors that require focused attention, strategic planning and 
action. An aging population in America — and a growing 
underserved population worldwide — have pushed traditional 
health-care delivery to a breaking point. We must be prepared to 
succeed in new models for the delivery of patient care. As well, 
funding from the National Institutes of Health has declined over 
the past decade. As a result, important work by our physician-
scientists to alleviate suering and disease is being delayed or 
deferred. Our response to the challenges that we face today will 
determine how successful we will be in the future.    
e continued support from our alumni and friends has 
never been more important, and I am condent that together we 
will continue to ourish, even in a dramatically changing world.
LARRY J.  SHAPIRO, MD
Executive Vice Chancellor for Medical Affairs  
and Dean, School of Medicine
A  L E T T E R  F R O M  T H E  D E A N  O F  T H E  S C H O O L  O F  M E D I C I N E
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Meeting the growing need for scholarships 
is an important challenge for the future and is a 
priority of the Leading Together campaign.  
Gordon W. Philpott, MD ’61, emeritus 
professor of surgery, is co-chairing the School 
of Medicine’s scholarship initiative committee. 
is initiative has secured nearly $22 million 
in endowed support toward a campaign goal of 
$40 million for endowed student 
support. Moreover, very signicant 
annual funds for scholarships have 
been received.  
Gordon and his wife, Susie, have 
supported their own annual and 
endowed scholarships. As Gordon 
explains, “We made a decision to add 
to the endowed scholarship started 
by my mother. In addition, my sister, 
Ann Augustin, and I wanted to make 
it a major scholarship to provide full 
support for a student.”
Tom Shane, MD ’06, was the 
rst recipient of the Philpott Family 
Scholarship, and Kavitha Rajeswari Sivaraman, 
MD ’10, was the second. Fourth-year student 
Marshall Strother now holds the scholarship.  
“We get to know the endowed scholarship students 
over a period of years, have dinner with them and 
meet their friends,” Gordon said. “ey even  
have invited us to their weddings, so they really 
become part of the family.”  
“It is fun to get to meet the new annual scholar-
ship students each year and it keeps us in touch 
with the school,” Susie added. 
Scholarship support reduces debt upon gradu-
ation and has an immediate impact on students’ 
lives. According to the Association of American 
Medical Colleges, medical students graduating in 
2013 had an average of nearly $170,000 of educa-
tion debt. e average indebtedness of Washington 
University School of Medicine Class of 2013 
graduates was just under $100,000 — more than 
40 percent less than the national average. 
Scholarships also are key to allowing future 
generations of students to pursue career paths 
based on passion, not on potential income. 
“When applying to medical schools, I braced 
myself for the possibility that I would be forced to 
choose between a school I wanted to attend and a 
school I could aord to attend,” said second-year 
student Ross Vyhmeister. “Scholarship funds made 
it possible for me to have the best of both worlds, 
enabling me to attend my rst-choice school with-
out excessive debt. I am grateful to be part of such 
a supportive community and look forward to the 
day when I can donate to a scholarship fund.” 
Supporting a dream
Scholarships allow
students to pursue
career paths based on
passion, not on income.
Susie and Gordon Philpott, MD, with annual scholarship recipients, left to right: Kelsey Rebehn, Jacob Witt, Taleef Khan, Lucas Dvoracek,
Ross Vyhmeister, James VandenBerg and Miles Bichanich.
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Together,  
  we learn.
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Up until now drug trials to treat Alzheimer’s 
disease aer dementia onset have been ineective; 
such discouraging results are not new to the  
long-fought Alzheimer’s disease eld. However,  
at Washington University School of Medicine,  
a recently launched drug trial — in those who  
do not yet have outward symptoms — may oer  
the possibility of success.
Ten years ago, Olga Mohan, 
a California pediatrician in the 
prime of her career, found diculty 
expressing her thoughts in words 
and was diagnosed with Alzheimer’s 
in her early 50s. “It is a horrible 
disease,” said her husband, Fred 
Simmons. “We want others who 
experience it through their family  
to have the best chance to avoid it.”
In learning about John C. Morris, 
MD, and his leading-edge Alzheimer’s 
research, the couple decided to 
make a gi. Morris, the Harvey A. 
and Dorismae Hacker Friedman 
Distinguished Professor in Neurology, directs  
the university’s Charles F. Knight Alzheimer’s 
Disease Research Center. 
“I believe John Morris is of the highest integ-
rity and intelligence,” Simmons said. “I learned 
exactly what John was 
doing, research-wise, 
and realized that it  
could have far-reaching 
implications.”
rough generous 
support provided by 
Olga Mohan, Fred 
Simmons and many 
others, new approaches 
are being pioneered at 
Washington University. 
Morris and colleague Randall J. Bateman, MD,  
the Charles F. and Joanne Knight Distinguished 
Professor of Neurology, have enlisted volunteers 
worldwide who have a rare, inherited form of 
Alzheimer’s disease that strikes much earlier in life. 
As a result, the new study, called the Dominantly 
Inherited Alzheimer’s Network Trials Unit 
(DIAN-TU), is focused on testing drugs that may 
provide a therapeutic benet at the disease’s earli-
est stages before symptoms begin. Prevention, the 
research suggests, has a better chance of succeed-
ing than treatment aer cognitive impairment. 
“If the study demonstrates ecacy, it will provide 
much needed hope that one day truly eective 
therapies for Alzheimer’s will be available,”  
Morris said. 
Effective treatments
Recently launched drug
trials — in those who do
not have outward symptoms
of Alzheimer’s —may offer
the chance of success.
John Morris, MD, and others at the Charles F. Knight Alzheimer’s Disease Research Center, are looking at treatment methods
that may help prevent the disease. He and Randall Bateman, MD, have enlisted volunteers worldwide to participate in a trial.
Together,  
  we discover.
Olga Mohan, MD, and  
Fred Simmons
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Continuing the vision
When Joel Siner, MD ’53, names his heroes, 
it is a “Who’s Who” of School of Medicine edu-
cators and visionaries: Barry Wood Jr., Carl V. 
Moore, Neal S. Bricker, Oliver Lowry, Tom Hunter 
and many others. ese are the individuals who 
inspired him as a student and taught him what it 
means to be a physician and a scientist.
He continues to nd inspiration and take pride 
in the physicians and researchers 
at Washington University, includ-
ing when he recently read a New 
England Journal of Medicine article 
outlining a landmark study on the 
acute myeloid leukemia (AML) 
genome. Written by members of the 
university’s Cancer Genome Atlas 
Research Network — including lead-
ers from e Genome Institute — 
the article prompted Siner to make  
a signicant gi to the institute  
for cancer genomic research. 
“We will use the gi to support 
our new eort to sequence every 
new AML patient who comes to the Siteman 
Cancer Center,” explained study co-author 
and institute director Richard K. Wilson, PhD, 
the Alan A. and Edith L. Wol Distinguished 
Professor of Medicine.
Lead author Timothy 
J. Ley, MD, the Lewis T. 
and Rosalind B. Apple 
Professor of Oncology 
and professor of medi-
cine and of genetics, 
adds, “We are at a 
crossroads in cancer 
genomics. Although 
much of the work has 
been done to identify 
the key mutations that cause many types of cancer, 
the next daunting step is how to get this informa-
tion into the clinic to help patients. 
“e early work will have to be supported by 
visionary gis like the one provided by Dr. Siner, 
since the major funding agencies need initial proof 
that the idea works before they will support the 
clinical application of genomics.”
As an internist, Siner was on the sta of Mount 
Auburn Hospital, the regional teaching hospital 
of Harvard Medical School. He also served as the 
hospital’s president and as a member of its board 
of Trustees from 1982-87. From 1996-2009, he 
served as a member of the internal review board at 
Harvard University. Retired from private practice 
since May 2000, Siner now lives in Cambridge, 
Mass., with his wife, Elinor, a retired psychiatrist. 
“We are at a crossroads
in cancer genomics.”
— Timothy Ley, MD
Timothy Ley, MD, left, and Richard Wilson, PhD, and their Washington University colleagues have identified virtually
all of the major mutations driving acute myeloid leukemia.
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Together,  
  we heal.
Joel Siner, MD
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Andy Chan with John and Andrea Atkinson Ron and Hanna Evens Philip and Sima K. Needleman
The Shawn Hu and Angela Zeng Fellowships support three students for one year. The fellows will 
conduct research in the Division of Laboratory and Genomic Medicine. From left: Angela Zeng, 
PhD, with the fellowship recipients — Stephen Ferris, Lulu Sun, Benjamin Solomon — and Barry 
Sleckman, MD, PhD, the Conan Professor of Laboratory and Genomic Medicine and division director.
As a postdoctoral fellow, Chris Holley, MD, PhD, left, worked alongside Jean Schaffer, MD, the Virginia Minnich Distinguished Professor of Medicine.
Holley now is an instructor of medicine.
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Enhance the career of a budding 
medical scientist by establishing 
an endowed or annual fellowship. 
Your fellowship support can benefit 
medical scientists in the Medical 
Scientist Training Program, the 
Division of Biology and Biomedical 
Sciences and in academic 
departments. Endowed or annual 
fellowships may be named 
in honor of the donor, a friend, 
family member or mentor, or in 
memory of a loved one.
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Fellows from the School of Medicine have outperformed 
and exceeded expectations in their respective elds, leav-
ing an impressive record of success. Fellowship support has 
helped many of these outstanding graduate students achieve 
their goals and aspirations.
Fellowship programs rely largely on government support, 
which has declined signicantly. As a result, the door is  
open for private philanthropy to have a major impact.
ose who support fellowship programs help to advance 
science and make the Washington University experience 
aordable for bright students with limited means. Fellow-
ships also are an opportunity to pay tribute to mentors  
or loved ones.
Honoring a mentor  Campaign committee member Andrew 
Chee-Yuen Chan, GM ’86, MD ’86, HS ’89, and his wife 
Mary Finnorn Chan, HS ’89, established the John P. 
Atkinson Fellowship to honor his mentor. rough the years, 
Atkinson, MD, the Samuel B. Grant Professor of Clinical 
Medicine and chief of the Division of Rheumatology, has 
helped launch the careers of many physician-scientists. 
is fellowship, which also has been supported by others, 
will be used to recruit the very best pre-doctoral students  
to train in human immunology — the focus of Atkinson’s 
long and remarkable research career.  
“e institution, and most importantly, the people at  
the institution have had very positive impacts on my life  
and career. I would encourage others to reect on the  
impact this institution has made in their life, and to think 
about what they can do to impact future trainees here,”  
said Andrew Chan. 
Advancing basic science  Philip Needleman, GR ’99, emeritus 
trustee of Washington University and campaign committee 
member, and his wife, Sima, MSW ’74, have established  
two annual fellowships.
“We want to attract the most vibrant and promising  
pre-doctoral students. To do this, nancial support is  
needed more than ever,” said Philip Needleman, also former 
professor and head of the Department of Pharmacology. 
e Philip and Sima K. Needleman Graduate Fellowships 
in Regenerative Medicine are under the direction of Lila 
Solnica-Krezel, PhD, chair of the Department of Developmental 
Biology (formerly the Department of Pharmacology).
“Regenerative medicine is a rapidly progressing discipline 
that develops treatments for a wide range of debilitating 
human diseases,” said Solnica-Krezel. “e Philip and  
Sima K. Needleman Graduate Fellowships will help to attract 
the brightest talent into the Developmental, Regenerative  
& Stem Cell Biology Program and advance regenerative 
medicine research at Washington University. With these  
fellowships, I am also particularly excited about continuing 
the tradition of scientic excellence established during  
Dr. Needleman’s tenure as the department chair.”
Helping the next generation  Research scholarships made  
it possible for Shawn Hu, MD, and his wife, Angela Zeng,  
PhD, MBA ’05, to come to the U.S. and pursue careers.  
e couple wants to help others by creating medical  
research opportunities.
e Shawn Hu and Angela Zeng Fellowships will support 
three students for one year, helping to restore critical train-
ing needs. 
 “Although our gradu-
ate program support 
grant from the National 
Institutes of Health 
received the highest possi-
ble score, we still lost three 
training slots because of 
general government bud-
get cuts,” explained Barry 
Sleckman, MD, PhD, 
the Conan Professor of 
Laboratory and Genomic 
Medicine and chief of the 
division. 
 “We are very excited to see our donation make a positive 
impact on people to whom we can relate from our own  
experience a couple of decades ago,” said Shawn Hu.  
“We have made a long-term commitment to contribute  
to the future success of the medical school.” 
Showing gratitude  e Ron and Hanna Evens Fellowship 
supports a postdoctoral fellowship in the Mallinckrodt 
Institute of Radiology (MIR). 
 “Hanna and I want to give back in appreciation for all 
that the School of Medicine, MIR and the entire Medical 
Campus has meant to us. Fellowships are fundamental  
to academic pursuit,” said Ronald G. Evens, MD ’64,  
formerly president of Barnes-Jewish Hospital and the 
Elizabeth Mallinckrodt Professor, head of the Department  
of Radiology and director of the Mallinckrodt Institute  
of Radiology. 
“Endowments that are for younger, up-and-coming  
professionals are especially worthwhile to Washington 
University and our constant drive to oer the very best  
care and education.” 
Fellowship support
“I would encourage
others to reflect on the
impact this institution has
made in their life ... .”
—  A N D R E W  C H A N
Together,  
  we lead.
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Together, we can change lives!
For information on supporting the School of Medicine 
through an outright gift, contact:
Pamela Buell, Associate Vice Chancellor for  
Medical Alumni and Development 
(314) 935-9698    email: meddev@wustl.edu 
  
Consult with your legal or tax adviser before making a charitable gift.
Planned giving benefits include:
n Significant charitable deductions
n Capital gain tax benefits
n Estate tax benefits
n Lifetime payments to you and/or loved ones
To learn how you can make a planned gift,  
contact the Oce of Planned Giving:
(800) 835-3503 or (314) 935-5373
plannedgiving.wustl.edu
Thank you to the many alumni and friends  
who have supported Leading Together: The 
Campaign for Washington University through an 
estate gift, life income plan or other planned gift.     
      Countless individuals will benefit from the life-
changing impact of the scholarships, professorships, 
research and clinical care these gifts will fund. 
Planned gifts shape the School of Medicine, from 
endowed scholarships, such as the Jackson Johnson 
Scholars, to innovative research centers, including  
the Grace Nelson Lacey Glaucoma Research Center. 
 Together
advancing health
transforming lives
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A world seldom seen
The visual systems of birds and reptiles are 
among the most sophisticated of any vertebrate. 
Turtles’ eyes, for example, contain oil droplets 
(above), which act like tiny lenses that help to 
distinguish colors. Joseph Corbo, MD, PhD, 
associate professor of pathology and immu-
nology, took this microscopic image of a painted 
turtle’s retina — magnified 400 times — and 
captured second prize in the 2013 Nikon  
Small World Photomicroscopy Contest. Using  
a technique called differential interference  
contrast microscopy, he reveals the light- 
sensitive cells of the eye called photoreceptors 
that contain these colorful droplets. 
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N O N P R O F I T  O R G .
U . S .  P O S T A G E
PA I D
S T.  L O U I S ,  M O
P E R M I T  2 5 3 5
Washington University School of Medicine 
Office of Medical Public Affairs  
Campus Box 8508  
4444 Forest Park Ave.  
St.  Louis, MO 63108
S P E E D I N G  S T R O K E  C A R E     A D V A N C I N G  P S Y C H I A T R Y     M A T C H  D A Y
Second-year MD/PhD student Kelly Hill captured this poetic winter scene along her running path in Forest Park.  
Washington University Medical Center is just visible above the trees  in this photo titled “Our Backyard.”
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